Control of drug release from capsules using high frequency energy transmission systems

International Journal of Pharmaceutics

Volumn 364, Issue 1, 2008, Pages 9-13

  Groning R ^a   Bensmann, H ^a   Muller R S ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Delayed drug release; Gas generating reactor; High frequency energy transmission system; Pulsed release; Tramadol

Indexed keywords

TRAMADOL;

ARTICLE; COMPUTER SYSTEM; CONTROLLED DRUG RELEASE; DELAYED DRUG RELEASE; DRUG CAPSULE; DRUG DELIVERY SYSTEM; ELECTROLYSIS; ENERGY; HIGH FREQUENCY ENERGY TRANSMISSION SYSTEM; OSCILLATION; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; SUSPENSION;

ANALGESICS, OPIOID; CAPSULES; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; ELECTROMAGNETIC FIELDS; ELECTRONICS; ENERGY TRANSFER; POLYPROPYLENES; POLYVINYL CHLORIDE; TRAMADOL;

EID: 53949105029     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.07.007     Document Type: Article

References (14)

1. Ahn J.M., Kang D.W., Kim H.C., and Min B.G. In vivo performance evaluation of a transcutaneous energy and information transmission system for the total artificial heart. ASAIO J. (1992) 39 (1993) M208-M212
2. Clear N.J., Milton A., Humphrey M., Henry B.T., Wulff M., Nichols D.J., Anziano R.J., and Wilding I. Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon. Eur. J. Pharm. Sci.: Official J. Eur. Fed. Pharm. Sci. 13 (2001) 375-384
3. Fryer T.B., Lund G.F., and Williams B.A. An inductively powered telemetry system for temperature, EKG, and activity monitoring. Biotelemetry Patient Monit. 5 (1978) 53-76
4. Gstoettner W., Adunka O., Hamzavi J., and Baumgartner W.D. Rehabilitation of hearing-impaired patients with cochlear implants: a review. Wiener klinische Wochenschrift 112 (2000) 464-472
5. Helmicki A.J., Melvin D.M., Henderson H.T., Nebrigic D., Venkat R., and Glos D.L. Development of a high permeability cored transintegumental power transformer. ASAIO J. (1992) 42 (1996) M624-M629
6. Laufen H., and Wildfeuer A. Absorption of isosorbide 5-nitrate from the gastrointestinal tract. Methods in Clinical Pharmacology 7 (1987) 76-81
7. Pavie A., Leger P., Leprince P., and Gandjbakhch I. Totally implantable completely electric artificial heart: "AbioCor". Archives des maladies du coeur et des vaisseaux 96 (2003) 934-938
8. Pithavala Y.K., Heizer W.D., Parr A.F., O'connor-Semmes R.L., and Brouwer K.L.R. Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract. Pharm. Res. 15 (1998) 1869-1875
9. Reilly J.P. Neuroelectric mechanisms applied to low frequency electric and magnetic field exposure guidelines. Part I. sinusoidal waveforms. Health Phys. 83 (2002) 341-355
10. Schuster O., and Hugemann B. Course of development of the HF-capsule - variations and method-related typical findings. Methods in Clinical Pharmacology 7 (1987) 28-38
11. Snyder A.J., Rosenberg G., Weiss W.J., Ford S.K., Nazarian R.A., Hicks D.L., Marlotte J.A., Kawaguchi O., Prophet G.A., and Sapirstein J.S. In vivo testing of a completely implanted total artificial heart system. ASAIO J. (1992) 39 (1993) M177-M184
12. Troyk P.R., and Schwan M.A. Closed-loop class E transcutaneous power and data link for microimplants. IEEE Transact. Bio-Med. Eng. 39 (1992) 589-599
13. Weiss W.J., Rosenberg G., Snyder A.J., Pae W.E., Richenbacher W.E., and Pierce W.S. In vivo performance of a transcutaneous energy transmission system with the Penn State motor driven ventricular assist device. ASAIO J. Transact. 35 (1989) 284-288
14. Zierhofer M.C., and Hochmair E.S. Transcutaneous transmission of digital data and energy in a cochlear prosthesis system. Int. J. Artif. Org. 15 (1992) 379-382